Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001455244-11-000025)

Filing Details

Accession Number:: 0001455244-11-000025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-05-18 10:39:45
Reporting Period:: 2011-05-16

Filing Date:: 2011-05-18
Accepted Time:: 2011-05-18 10:39:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
72444	Nabi Biopharmaceuticals	NABI	Biological Products, (No Disgnostic Substances) (2836)	591212264

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1428524	D. Paul Kessler	C/O Nabi Biopharmaceuticals 12276 Wilkins Ave Rockville MD 20852	Svp Clinical, Med. & Reg.; Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-05-16	7,500	$5.53	115,171	No	4	S	Direct
Common Stock	Disposition	2011-05-16	4,876	$5.48	110,295	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.